Cargando…
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
The potential for adoptive cell immunotherapy as a treatment against cancers has been demonstrated by the remarkable response in some patients with hematological malignancies using autologous T cells endowed with chimeric antigen receptors (CARs) specific for CD19. Clinical efficacy of CAR-T cell th...
Autores principales: | Zhang, Erhao, Gu, Jieyi, Xu, Hanmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767005/ https://www.ncbi.nlm.nih.gov/pubmed/29329591 http://dx.doi.org/10.1186/s12943-018-0759-3 |
Ejemplares similares
-
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
por: Zhang, Erhao, et al.
Publicado: (2017) -
Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12
por: Chi, Xiaowei, et al.
Publicado: (2019) -
Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
por: Guo, Yelei, et al.
Publicado: (2016) -
Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
por: Yan, Lingli, et al.
Publicado: (2018) -
Chimeric antigen receptor T-cell therapy for solid tumors
por: Newick, Kheng, et al.
Publicado: (2016)